11/21/2024

Janusmed amning

Janusmed amning – Lacosamide STADA

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
3 3
3 3

Lakosamid

Lakosamid

Klass : 3

Visa all info

Skriv ut

Kontakta oss

  1. Ylikotila P, Ketola RA, Timonen S, Malm H, Ruuskanen JO. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod Toxicol. 2015;57:204-6.

  2. Landmark CJ, Rektorli L, Burns ML, Revdal E, Johannessen SI, Brodtkorb E. Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation. Epileptic Disord. 2021;23(2):426-431.

  3. Zarubova J, Kremlackova V, Borecka K, Marusic . Plasma and breast milk levels of lacosamidebefore, during and post pregnancy. Epilepsia . 2016;57(57):69.

  4. Lattanzi S, Cagnetti C, Foschi N, Provinciali L, Silvestrini M. Lacosamide during pregnancy and breastfeeding. Neurol Neurochir Pol. 2017;51(3):266-269.

  5. Cercos M, Seqat I, Facile A, Vial T, Auffret M. Lacosamide use during breastfeeding: A case report and a literature review. Fundam Clin Pharmacol. 2024;38(3):575-578.

  6. Kacirova I, Urinovska R, Grundmann M. Therapeutic monitoring of lacosamide, perampanel, and zonisamide during breastfeeding. Epilepsy Res. 2024;199:107264.

  7. Bosak M, Wȩzyk K. Uneventful pregnancy on lacosamide monotherapy. Epilepsia 2021;62(Suppl 3):355-6. doi:10.1111/epi.17079 [CrossRef]

  8. Bosak M, Dziedzic R, Matwiej K, Słowik A. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series. Neurol Neurochir Pol. 2024;58(2):203-206.

  1. Ylikotila P, Ketola RA, Timonen S, Malm H, Ruuskanen JO. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod Toxicol. 2015;57:204-6.
  2. Landmark CJ, Rektorli L, Burns ML, Revdal E, Johannessen SI, Brodtkorb E. Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation. Epileptic Disord. 2021;23(2):426-431.
  3. Zarubova J, Kremlackova V, Borecka K, Marusic . Plasma and breast milk levels of lacosamidebefore, during and post pregnancy. Epilepsia . 2016;57(57):69.
  4. Lattanzi S, Cagnetti C, Foschi N, Provinciali L, Silvestrini M. Lacosamide during pregnancy and breastfeeding. Neurol Neurochir Pol. 2017;51(3):266-269.
  5. Cercos M, Seqat I, Facile A, Vial T, Auffret M. Lacosamide use during breastfeeding: A case report and a literature review. Fundam Clin Pharmacol. 2024;38(3):575-578.
  6. Kacirova I, Urinovska R, Grundmann M. Therapeutic monitoring of lacosamide, perampanel, and zonisamide during breastfeeding. Epilepsy Res. 2024;199:107264.
  7. Bosak M, Wȩzyk K. Uneventful pregnancy on lacosamide monotherapy. Epilepsia 2021;62(Suppl 3):355-6. doi:10.1111/epi.17079 [CrossRef]
  8. Bosak M, Dziedzic R, Matwiej K, Słowik A. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series. Neurol Neurochir Pol. 2024;58(2):203-206.

Innehållet senast uppdaterat 11/7/2024